Apimeds Pharmaceuticals US Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| HEMENWAY TRUST CO LLC | 08/11/2026 | 274.00 K | $246.60 K | 0.00% | 1.68% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 63.65 K | $57.29 K | -33.64% | 0.39% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 35.11 K | $31.60 K | -12.33% | 0.22% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 24.04 K | $21.64 K | 0.00% | 0.15% |
| JANE STREET GROUP, LLC | 08/14/2026 | 15.99 K | $14.39 K | 100.00% | 0.10% |
| UBS GROUP AG | 08/13/2026 | 11.82 K | $10.64 K | 182.25% | 0.07% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 1.66 K | $1.50 K | 100.00% | 0.01% |
| TWO SIGMA SECURITIES, LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Apimeds Pharmaceuticals US Inc. institutional Ownership - FAQ's
During the previous two years, 9 institutional investors and hedge funds held shares of Apimeds Pharmaceuticals US Inc.. The most heavily invested institutionals were:
Hemenway Trust Co LLC: 274,000
VANGUARD CAPITAL MANAGEMENT LLC: 63,654
GEODE CAPITAL MANAGEMENT, LLC: 35,114
VANGUARD FIDUCIARY TRUST CO: 24,039
JANE STREET GROUP, LLC: 15,993
UBS Group AG: 11,818
2.61% of Apimeds Pharmaceuticals US Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 485.27 K shares in the last 24 months. This purchase volume represents approximately $635.71 K in transactions.